Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.37B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$488M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$449M |
| 4 |
Apple
AAPL
|
+$402M |
| 5 |
HES
Hess
HES
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.47B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$1.44B |
| 3 |
NVIDIA
NVDA
|
+$783M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$722M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$650M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Healthcare | 6.09% |
| 3 | Financials | 5% |
| 4 | Consumer Discretionary | 4.53% |
| 5 | Industrials | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
CALL
General Motors
GM
$77.2B
| $118M | 0.05% |
3,294,000
+1,411,500
| +75% | +$43.7M |
|
352
PUT
Pfizer
PFE
$160B
| $118M | 0.05% |
4,106,700
+1,320,400
| +47% | +$39.9M |
|
353
Crown Castle
CCI
$32.1B
| $118M | 0.05% |
1,026,058
+473,122
| +86% | +$48.5M |
|
354
Fortinet
FTNT
$113B
| $118M | 0.05% |
2,017,783
+1,474,968
| +272% | +$81.5M |
|
355
DraftKings
DKNG
$13B
| $118M | 0.05% |
3,348,538
+1,462,541
| +78% | +$48.9M |
|
356
Constellation Brands
STZ
$23.2B
| $116M | 0.05% |
480,404
-500,619
| -51% | -$119M |
|
357
Valero Energy
VLO
$100B
| $116M | 0.05% |
891,961
+31,698
| +4% | +$4.03M |
|
358
CALL
State Street SPDR S&P Biotech ETF
XBI
$11.2B
| $116M | 0.05% |
1,297,700
+449,900
| +53% | +$33.4M |
|
359
CALL
Amgen
AMGN
$238B
| $116M | 0.05% |
401,300
-62,400
| -13% | -$17M |
|
360
Northrop Grumman
NOC
$78.3B
| $115M | 0.05% |
246,276
-79,693
| -24% | -$37.4M |
|
361
Expedia Group
EXPE
$38.6B
| $115M | 0.05% |
759,448
+348,689
| +85% | +$42.7M |
|
362
International Flavors & Fragrances
IFF
$21.5B
| $115M | 0.05% |
1,418,415
+79,637
| +6% | +$5.76M |
|
363
Analog Devices
ADI
$182B
| $114M | 0.05% |
575,381
+350,899
| +156% | +$62.7M |
|
364
PUT
Union Pacific
UNP
$183B
| $114M | 0.05% |
462,900
-220,800
| -32% | -$48.5M |
|
365
CALL
Texas Instruments
TXN
$241B
| $113M | 0.05% |
665,600
+138,200
| +26% | +$21.4M |
|
366
LivaNova
LIVN
$4.34B
| $113M | 0.05% |
2,188,535
+222,999
| +11% | +$10.8M |
|
|
AMED
367
DELISTED
Amedisys
AMED
| $113M | 0.05% |
1,187,176
+380,411
| +47% | +$35.5M |
|
368
Pinduoduo
PDD
$126B
| $113M | 0.05% |
771,067
+66,591
| +9% | +$8.08M |
|
369
Kroger
KR
$35.5B
| $113M | 0.05% |
2,465,071
+1,982,720
| +411% | +$88.1M |
|
370
BioMarin Pharmaceuticals
BMRN
$12.9B
| $113M | 0.05% |
1,168,355
+904,404
| +343% | +$80M |
|
371
Nutanix
NTNX
$18.3B
| $113M | 0.05% |
2,360,246
+1,845,241
| +358% | +$74.7M |
|
372
Corteva
CTVA
$54.6B
| $112M | 0.05% |
2,346,288
+1,413,630
| +152% | +$67.4M |
|
373
Eaton
ETN
$163B
| $112M | 0.05% |
466,733
+191,854
| +70% | +$42.3M |
|
374
Nutrien
NTR
$35.9B
| $112M | 0.05% |
1,995,153
+386,929
| +24% | +$21.9M |
|
375
PUT
Uber
UBER
$161B
| $112M | 0.05% |
1,823,100
+1,463,500
| +407% | +$76.6M |
|
Similar funds
Israel Englander's Q4 2023 Portfolio in Review
As of Q4 2023, Israel Englander held 6,891 positions worth $231B, up 17% from $198B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $7.99B of net new capital in Q4 2023, opening 816 new positions and adding to 2,304 existing holdings. Its largest new stake was Ferguson: 906,589 shares worth $175M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 9.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.47B trimmed.
- Israel Englander's largest Q4 2023 buy was Ferguson: 906,589 shares worth $175M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $4.37B increase.
- Israel Englander's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.47B.
- Israel Englander fully exited Activision Blizzard in Q4 2023, selling an estimated $1.44B.
- Israel Englander's ten largest holdings make up 21% of its $231B portfolio in Q4 2023.
- Israel Englander opened 816 new positions and closed 883 in Q4 2023.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $231B.
Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.